ID   DHSD_HUMAN              Reviewed;         159 AA.
AC   O14521; A6ND90; B3KQQ8; E9PIC0; E9PIG3; E9PQI9; Q53XW5; Q6IRW2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   15-MAR-2017, entry version 182.
DE   RecName: Full=Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial;
DE            Short=CybS;
DE   AltName: Full=CII-4;
DE   AltName: Full=QPs3;
DE   AltName: Full=Succinate dehydrogenase complex subunit D;
DE   AltName: Full=Succinate-ubiquinone oxidoreductase cytochrome b small subunit;
DE   AltName: Full=Succinate-ubiquinone reductase membrane anchor subunit;
DE   Flags: Precursor;
GN   Name=SDHD; Synonyms=SDH4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=9533030;
RA   Hirawake H., Taniwaki M., Tamura A., Kojima S., Kita K.;
RT   "Cytochrome b in human complex II (succinate-ubiquinone
RT   oxidoreductase): cDNA cloning of the components in liver mitochondria
RT   and chromosome assignment of the genes for the large (SDHC) and small
RT   (SDHD) subunits to 1q21 and 11q23.";
RL   Cytogenet. Cell Genet. 79:132-138(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10482792; DOI=10.1016/S0005-2728(99)00071-7;
RA   Hirawake H., Taniwaki M., Tamura A., Amino H., Tomitsuka E., Kita K.;
RT   "Characterization of the human SDHD gene encoding the small subunit of
RT   cytochrome b (cybS) in mitochondrial succinate-ubiquinone
RT   oxidoreductase.";
RL   Biochim. Biophys. Acta 1412:295-300(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, Brain, Lung, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   VARIANT PHEOCHROMOCYTOMA LEU-81.
RX   PubMed=11156372;
RA   Gimm O., Armanios M., Dziema H., Neumann H.P.H., Eng C.;
RT   "Somatic and occult germ-line mutations in SDHD, a mitochondrial
RT   complex II gene, in nonfamilial pheochromocytoma.";
RL   Cancer Res. 60:6822-6825(2000).
RN   [13]
RP   VARIANTS PGL1 LEU-81; TYR-92 AND LEU-102.
RX   PubMed=10657297; DOI=10.1126/science.287.5454.848;
RA   Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C.,
RA   Myssiorek D., Bosch A., van der Mey A., Taschner P.E.M.,
RA   Rubinstein W.S., Myers E.N., Richard C.W. III, Cornelisse C.J.,
RA   Devilee P., Devlin B.;
RT   "Mutations in SDHD, a mitochondrial complex II gene, in hereditary
RT   paraganglioma.";
RL   Science 287:848-851(2000).
RN   [14]
RP   VARIANT PGL1 CYS-114.
RX   PubMed=11343322; DOI=10.1002/ajmg.1270;
RA   Milunsky J.M., Maher T.A., Michels V.V., Milunsky A.;
RT   "Novel mutations and the emergence of a common mutation in the SDHD
RT   gene causing familial paraganglioma.";
RL   Am. J. Med. Genet. 100:311-314(2001).
RN   [15]
RP   VARIANT PGL1 TYR-93 DEL.
RX   PubMed=11391796; DOI=10.1002/gcc.1142;
RA   Badenhop R.F., Cherian S., Lord R.S.A., Baysal B.E., Taschner P.E.M.,
RA   Schofield P.R.;
RT   "Novel mutations in the SDHD gene in pedigrees with familial carotid
RT   body paraganglioma and sensorineural hearing loss.";
RL   Genes Chromosomes Cancer 31:255-263(2001).
RN   [16]
RP   VARIANTS PGL1 TYR-92 AND PRO-139.
RX   PubMed=11391798; DOI=10.1002/gcc.1144;
RA   Taschner P.E.M., Jansen J.C., Baysal B.E., Bosch A., Rosenberg E.H.,
RA   Broecker-Vriends A.H.J.T., van Der Mey A.G.L., van Ommen G.-J.B.,
RA   Cornelisse C.J., Devilee P.;
RT   "Nearly all hereditary paragangliomas in the Netherlands are caused by
RT   two founder mutations in the SDHD gene.";
RL   Genes Chromosomes Cancer 31:274-281(2001).
RN   [17]
RP   VARIANT SER-12.
RX   PubMed=11526495; DOI=10.1038/sj.onc.1204579;
RA   Masuoka J., Brandner S., Paulus W., Soffer D., Vital A., Chimelli L.,
RA   Jouvet A., Yonekawa Y., Kleihues P., Ohgaki H.;
RT   "Germline SDHD mutation in paraganglioma of the spinal cord.";
RL   Oncogene 20:5084-5086(2001).
RN   [18]
RP   INVOLVEMENT IN INTESTINAL CARCINOID TUMOR, AND VARIANTS SER-12 AND
RP   ARG-50.
RX   PubMed=12007193; DOI=10.1002/gcc.10081;
RA   Kytoelae S., Nord B., Elder E.E., Carling T., Kjellman M.,
RA   Cedermark B., Juhlin C., Hoeoeg A., Isola J., Larsson C.;
RT   "Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell
RT   carcinomas, pheochromocytomas, and abdominal paragangliomas.";
RL   Genes Chromosomes Cancer 34:325-332(2002).
RN   [19]
RP   VARIANTS SER-12 AND ARG-50.
RX   PubMed=14500403;
RA   Gimenez-Roqueplo A.-P., Favier J., Rustin P., Rieubland C.,
RA   Crespin M., Nau V., Khau Van Kien P., Corvol P., Plouin P.-F.,
RA   Jeunemaitre X.;
RT   "Mutations in the SDHB gene are associated with extra-adrenal and/or
RT   malignant phaeochromocytomas.";
RL   Cancer Res. 63:5615-5621(2003).
RN   [20]
RP   VARIANT PHEOCHROMOCYTOMA TYR-92.
RX   PubMed=12000816; DOI=10.1056/NEJMoa020152;
RG   The Freiburg-Warsaw-Columbus pheochromocytoma study group;
RA   Neumann H.P.H., Bausch B., McWhinney S.R., Bender B.U., Gimm O.,
RA   Franke G., Schipper J., Klisch J., Altehoefer C., Zerres K.,
RA   Januszewicz A., Smith W.M., Munk R., Manz T., Glaesker S., Apel T.W.,
RA   Treier M., Reineke M., Walz M.K., Hoang-Vu C., Brauckhoff M.,
RA   Klein-Franke A., Klose P., Schmidt H., Maier-Woelfle M.,
RA   Peczkowska M., Szmigielski C., Eng C.;
RT   "Germ-line mutations in nonsyndromic pheochromocytoma.";
RL   N. Engl. J. Med. 346:1459-1466(2002).
RN   [21]
RP   DISCUSSION OF PATHOGENIC ROLE OF VARIANTS SER-12 AND ARG-50.
RX   PubMed=12696072; DOI=10.1002/gcc.10212;
RA   Cascon A., Ruiz-Llorente S., Cebrian A., Leton R., Telleria D.,
RA   Benitez J., Robledo M.;
RT   "G12S and H50R variations are polymorphisms in the SDHD gene.";
RL   Genes Chromosomes Cancer 37:220-221(2003).
RN   [22]
RP   VARIANTS PGL1 LEU-81; CYS-114 AND VAL-148, AND VARIANT
RP   PHEOCHROMOCYTOMA TYR-92.
RX   PubMed=15328326; DOI=10.1001/jama.292.8.943;
RA   Neumann H.P.H., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R.,
RA   Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., Hoegerle S.,
RA   Boedeker C.C., Opocher G., Schipper J., Januszewicz A., Eng C.;
RT   "Distinct clinical features of paraganglioma syndromes associated with
RT   SDHB and SDHD gene mutations.";
RL   JAMA 292:943-951(2004).
RN   [23]
RP   ERRATUM.
RA   Neumann H.P.H., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R.,
RA   Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., Hoegerle S.,
RA   Boedeker C.C., Opocher G., Schipper J., Januszewicz A., Eng C.;
RL   JAMA 292:1686-1686(2004).
RN   [24]
RP   VARIANT SER-12.
RX   PubMed=15032977; DOI=10.1111/j..2004.00174.x;
RA   Leube B., Huber R., Goecke T.O., Sandmann W., Royer-Pokora B.;
RT   "SDHD mutation analysis in seven German patients with sporadic carotid
RT   body paraganglioma: one novel mutation, no Dutch founder mutation and
RT   further evidence that G12S is a polymorphism.";
RL   Clin. Genet. 65:61-63(2004).
RN   [25]
RP   INVOLVEMENT IN PGGSS.
RX   PubMed=17804857; DOI=10.1056/NEJMc071191;
RA   McWhinney S.R., Pasini B., Stratakis C.A.;
RT   "Familial gastrointestinal stromal tumors and germ-line mutations.";
RL   N. Engl. J. Med. 357:1054-1056(2007).
RN   [26]
RP   VARIANTS SER-12; ARG-50 AND ASN-145, CHARACTERIZATION OF VARIANTS
RP   SER-12; ARG-50 AND ASN-145, AND INVOLVEMENT IN CWS3.
RX   PubMed=18678321; DOI=10.1016/j.ajhg.2008.07.011;
RA   Ni Y., Zbuk K.M., Sadler T., Patocs A., Lobo G., Edelman E.,
RA   Platzer P., Orloff M.S., Waite K.A., Eng C.;
RT   "Germline mutations and variants in the succinate dehydrogenase genes
RT   in Cowden and Cowden-like syndromes.";
RL   Am. J. Hum. Genet. 83:261-268(2008).
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-12.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [28]
RP   VARIANT MT-C2D LYS-69, CHARACTERIZATION OF VARIANT MT-C2D LYS-69, AND
RP   INVOLVEMENT IN MT-C2D.
RX   PubMed=24367056; DOI=10.1136/jmedgenet-2013-101932;
RA   Jackson C.B., Nuoffer J.M., Hahn D., Prokisch H., Haberberger B.,
RA   Gautschi M., Haeberli A., Gallati S., Schaller A.;
RT   "Mutations in SDHD lead to autosomal recessive encephalomyopathy and
RT   isolated mitochondrial complex II deficiency.";
RL   J. Med. Genet. 51:170-175(2014).
RN   [29]
RP   VARIANT MT-C2D GLY-92, INVOLVEMENT IN MT-C2D, AND CHARACTERIZATION OF
RP   VARIANT MT-C2D GLY-92.
RX   PubMed=26008905; DOI=10.1007/s00439-015-1568-z;
RA   Alston C.L., Ceccatelli Berti C., Blakely E.L., Olahova M., He L.,
RA   McMahon C.J., Olpin S.E., Hargreaves I.P., Nolli C., McFarland R.,
RA   Goffrini P., O'Sullivan M.J., Taylor R.W.;
RT   "A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal
RT   cardiomyopathy and a severe mitochondrial complex II deficiency.";
RL   Hum. Genet. 134:869-879(2015).
CC   -!- FUNCTION: Membrane-anchoring subunit of succinate dehydrogenase
CC       (SDH) that is involved in complex II of the mitochondrial electron
CC       transport chain and is responsible for transferring electrons from
CC       succinate to ubiquinone (coenzyme Q). {ECO:0000250}.
CC   -!- PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle.
CC   -!- SUBUNIT: Component of complex II composed of four subunits: the
CC       flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a
CC       cytochrome b560 composed of SDHC and SDHD.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O14521-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14521-2; Sequence=VSP_054744;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC       Name=3;
CC         IsoId=O14521-3; Sequence=VSP_054745;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC       Name=4;
CC         IsoId=O14521-4; Sequence=VSP_054746, VSP_054747;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- DISEASE: Paragangliomas 1 (PGL1) [MIM:168000]: A neural crest
CC       tumor usually derived from the chromoreceptor tissue of a
CC       paraganglion. PGL1 is a rare autosomal dominant disorder which is
CC       characterized by the development of mostly benign, highly
CC       vascular, slowly growing tumors in the head and neck. In the head
CC       and neck region, the carotid body is the largest of all
CC       paraganglia and is also the most common site of the tumors.
CC       {ECO:0000269|PubMed:10657297, ECO:0000269|PubMed:11343322,
CC       ECO:0000269|PubMed:11391796, ECO:0000269|PubMed:11391798,
CC       ECO:0000269|PubMed:15328326}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Pheochromocytoma (PCC) [MIM:171300]: A catecholamine-
CC       producing tumor of chromaffin tissue of the adrenal medulla or
CC       sympathetic paraganglia. The cardinal symptom, reflecting the
CC       increased secretion of epinephrine and norepinephrine, is
CC       hypertension, which may be persistent or intermittent.
CC       {ECO:0000269|PubMed:11156372, ECO:0000269|PubMed:12000816,
CC       ECO:0000269|PubMed:15328326}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Intestinal carcinoid tumor (ICT) [MIM:114900]: A yellow,
CC       well-differentiated, circumscribed tumor that arises from
CC       enterochromaffin cells in the small intestine or, less frequently,
CC       in other parts of the gastrointestinal tract.
CC       {ECO:0000269|PubMed:12007193}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Paraganglioma and gastric stromal sarcoma (PGGSS)
CC       [MIM:606864]: Gastrointestinal stromal tumors may be sporadic or
CC       inherited in an autosomal dominant manner, alone or as a component
CC       of a syndrome associated with other tumors, such as in the context
CC       of neurofibromatosis type 1 (NF1). Patients have both
CC       gastrointestinal stromal tumors and paragangliomas. Susceptibility
CC       to the tumors was inherited in an apparently autosomal dominant
CC       manner, with incomplete penetrance. {ECO:0000269|PubMed:17804857}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Cowden syndrome 3 (CWS3) [MIM:615106]: A form of Cowden
CC       syndrome, a hamartomatous polyposis syndrome with age-related
CC       penetrance. Cowden syndrome is characterized by hamartomatous
CC       lesions affecting derivatives of ectodermal, mesodermal and
CC       endodermal layers, macrocephaly, facial trichilemmomas (benign
CC       tumors of the hair follicle infundibulum), acral keratoses,
CC       papillomatous papules, and elevated risk for development of
CC       several types of malignancy, particularly breast carcinoma in
CC       women and thyroid carcinoma in both men and women. Colon cancer
CC       and renal cell carcinoma have also been reported. Hamartomas can
CC       be found in virtually every organ, but most commonly in the skin,
CC       gastrointestinal tract, breast and thyroid.
CC       {ECO:0000269|PubMed:18678321}. Note=The disease may be caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial complex II deficiency (MT-C2D)
CC       [MIM:252011]: A disorder of the mitochondrial respiratory chain
CC       with heterogeneous clinical manifestations. Clinical features
CC       include psychomotor regression in infants, poor growth with lack
CC       of speech development, severe spastic quadriplegia, dystonia,
CC       progressive leukoencephalopathy, muscle weakness, exercise
CC       intolerance, cardiomyopathy. Some patients manifest Leigh syndrome
CC       or Kearns-Sayre syndrome. {ECO:0000269|PubMed:24367056,
CC       ECO:0000269|PubMed:26008905}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CybS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SDHDID390.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=SDHD entry;
CC       URL="https://en.wikipedia.org/wiki/SDHD";
CC   -!- WEB RESOURCE: Name=TCA Cycle Gene Mutation Database;
CC       URL="http://databases.lovd.nl/shared/genes/SDHD";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB006202; BAA22054.1; -; mRNA.
DR   EMBL; AB026906; BAA81889.1; -; Genomic_DNA.
DR   EMBL; AK075360; BAG52120.1; -; mRNA.
DR   EMBL; BT007238; AAP35902.1; -; mRNA.
DR   EMBL; CR456932; CAG33213.1; -; mRNA.
DR   EMBL; AP002007; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67181.1; -; Genomic_DNA.
DR   EMBL; BC005263; AAH05263.1; -; mRNA.
DR   EMBL; BC009574; AAH09574.1; -; mRNA.
DR   EMBL; BC012603; AAH12603.1; -; mRNA.
DR   EMBL; BC015188; AAH15188.1; -; mRNA.
DR   EMBL; BC015992; AAH15992.1; -; mRNA.
DR   EMBL; BC022350; AAH22350.1; -; mRNA.
DR   EMBL; BC070307; AAH70307.1; -; mRNA.
DR   EMBL; BC071755; AAH71755.1; -; mRNA.
DR   EMBL; BC071756; AAH71756.1; -; mRNA.
DR   CCDS; CCDS31678.1; -. [O14521-1]
DR   CCDS; CCDS60958.1; -. [O14521-4]
DR   CCDS; CCDS60959.1; -. [O14521-3]
DR   CCDS; CCDS60960.1; -. [O14521-2]
DR   RefSeq; NP_001263432.1; NM_001276503.1. [O14521-3]
DR   RefSeq; NP_001263433.1; NM_001276504.1. [O14521-2]
DR   RefSeq; NP_001263435.1; NM_001276506.1. [O14521-4]
DR   RefSeq; NP_002993.1; NM_003002.3. [O14521-1]
DR   UniGene; Hs.356270; -.
DR   UniGene; Hs.744039; -.
DR   ProteinModelPortal; O14521; -.
DR   SMR; O14521; -.
DR   BioGrid; 112293; 1.
DR   IntAct; O14521; 2.
DR   STRING; 9606.ENSP00000364699; -.
DR   DrugBank; DB00756; Hexachlorophene.
DR   DrugBank; DB00139; Succinic acid.
DR   DrugBank; DB08689; UBIQUINONE-1.
DR   SwissPalm; O14521; -.
DR   EPD; O14521; -.
DR   MaxQB; O14521; -.
DR   PaxDb; O14521; -.
DR   PeptideAtlas; O14521; -.
DR   PRIDE; O14521; -.
DR   TopDownProteomics; O14521-1; -. [O14521-1]
DR   DNASU; 6392; -.
DR   Ensembl; ENST00000375549; ENSP00000364699; ENSG00000204370. [O14521-1]
DR   Ensembl; ENST00000525291; ENSP00000436669; ENSG00000204370. [O14521-2]
DR   Ensembl; ENST00000526592; ENSP00000432005; ENSG00000204370. [O14521-4]
DR   Ensembl; ENST00000528048; ENSP00000436217; ENSG00000204370. [O14521-3]
DR   Ensembl; ENST00000614349; ENSP00000480666; ENSG00000204370. [O14521-4]
DR   GeneID; 6392; -.
DR   KEGG; hsa:6392; -.
DR   UCSC; uc001pmz.5; human. [O14521-1]
DR   CTD; 6392; -.
DR   DisGeNET; 6392; -.
DR   GeneCards; SDHD; -.
DR   GeneReviews; SDHD; -.
DR   H-InvDB; HIX0029526; -.
DR   HGNC; HGNC:10683; SDHD.
DR   HPA; HPA045727; -.
DR   MalaCards; SDHD; -.
DR   MIM; 114900; phenotype.
DR   MIM; 168000; phenotype.
DR   MIM; 171300; phenotype.
DR   MIM; 252011; phenotype.
DR   MIM; 602690; gene.
DR   MIM; 606864; phenotype.
DR   MIM; 615106; phenotype.
DR   neXtProt; NX_O14521; -.
DR   OpenTargets; ENSG00000204370; -.
DR   Orphanet; 100093; Carcinoid tumor and carcinoid syndrome.
DR   Orphanet; 97286; Carney-Stratakis syndrome.
DR   Orphanet; 201; Cowden syndrome.
DR   Orphanet; 29072; Hereditary pheochromocytoma-paraganglioma.
DR   Orphanet; 3208; Isolated succinate-CoQ reductase deficiency.
DR   PharmGKB; PA35608; -.
DR   eggNOG; KOG4097; Eukaryota.
DR   eggNOG; ENOG4111RTW; LUCA.
DR   GeneTree; ENSGT00390000010003; -.
DR   HOGENOM; HOG000290645; -.
DR   HOVERGEN; HBG003003; -.
DR   InParanoid; O14521; -.
DR   KO; K00237; -.
DR   OMA; PCSAVDY; -.
DR   OrthoDB; EOG091G0RHX; -.
DR   PhylomeDB; O14521; -.
DR   TreeFam; TF313310; -.
DR   BioCyc; MetaCyc:ENSG00000150781-MONOMER; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   Reactome; R-HSA-71403; Citric acid cycle (TCA cycle).
DR   SIGNOR; O14521; -.
DR   UniPathway; UPA00223; -.
DR   ChiTaRS; SDHD; human.
DR   GeneWiki; SDHD; -.
DR   GenomeRNAi; 6392; -.
DR   PRO; PR:O14521; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000204370; -.
DR   CleanEx; HS_SDHD; -.
DR   ExpressionAtlas; O14521; baseline and differential.
DR   Genevisible; O14521; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005740; C:mitochondrial envelope; TAS:ProtInc.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005749; C:mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone); ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; TAS:ProtInc.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000104; F:succinate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0048039; F:ubiquinone binding; ISS:UniProtKB.
DR   GO; GO:0006121; P:mitochondrial electron transport, succinate to ubiquinone; IBA:GO_Central.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB.
DR   CDD; cd03496; SQR_TypeC_CybS; 1.
DR   InterPro; IPR007992; CybS.
DR   PANTHER; PTHR13337; PTHR13337; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Electron transport; Heme; Iron; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Polymorphism;
KW   Reference proteome; Transit peptide; Transmembrane;
KW   Transmembrane helix; Transport; Tricarboxylic acid cycle.
FT   TRANSIT       1     56       Mitochondrion. {ECO:0000255}.
FT   CHAIN        57    159       Succinate dehydrogenase [ubiquinone]
FT                                cytochrome b small subunit,
FT                                mitochondrial.
FT                                /FTId=PRO_0000006487.
FT   TOPO_DOM     57     63       Mitochondrial matrix. {ECO:0000250}.
FT   TRANSMEM     64     85       Helical. {ECO:0000250}.
FT   TOPO_DOM     86     90       Mitochondrial intermembrane.
FT                                {ECO:0000250}.
FT   TRANSMEM     91    111       Helical. {ECO:0000250}.
FT   TOPO_DOM    112    120       Mitochondrial matrix. {ECO:0000250}.
FT   TRANSMEM    121    142       Helical. {ECO:0000250}.
FT   TOPO_DOM    143    159       Mitochondrial intermembrane.
FT                                {ECO:0000250}.
FT   METAL       102    102       Iron (heme axial ligand); shared with
FT                                SDHC. {ECO:0000250}.
FT   BINDING     114    114       Ubiquinone; shared with IP/SDHB.
FT                                {ECO:0000250}.
FT   VAR_SEQ      19     57       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_054744.
FT   VAR_SEQ      56    158       HSGSKAASLHWTSERVVSVLLLGLLPAAYLNPCSAMDYSLA
FT                                AALTLHGHWGLGQVVTDYVHGDALQKAAKAGLLALSALTFA
FT                                GLCYFNYHDVGICKAVAMLWK -> HWALDKLLLTMFMGMP
FT                                CRKLPRQGFWHFQ (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_054745.
FT   VAR_SEQ     106    143       GLGQVVTDYVHGDALQKAAKAGLLALSALTFAGLCYFN ->
FT                                LECNGAILARHDLGSARSQLTATSAFRVQAILLPQPPK
FT                                (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_054746.
FT   VAR_SEQ     144    159       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_054747.
FT   VARIANT      12     12       G -> S (polymorphism that may increase
FT                                susceptibility for developing
FT                                pheochromocytoma, paraganglioma,
FT                                intestinal carcinoid tumor and breast,
FT                                renal and uterus carcinoma; may be
FT                                associated with Cowden syndrome;
FT                                associated with increased manganese
FT                                superoxide dismutase expression;
FT                                associated with increased reactive oxygen
FT                                species; associated with 1.9-fold
FT                                increase in both AKT and MAPK expression;
FT                                dbSNP:rs34677591).
FT                                {ECO:0000269|PubMed:11526495,
FT                                ECO:0000269|PubMed:12007193,
FT                                ECO:0000269|PubMed:12696072,
FT                                ECO:0000269|PubMed:14500403,
FT                                ECO:0000269|PubMed:15032977,
FT                                ECO:0000269|PubMed:18678321,
FT                                ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_017870.
FT   VARIANT      50     50       H -> R (polymorphism that may increase
FT                                susceptibility for developing
FT                                paraganglioma, breast and thyroid
FT                                carcinoma; may be involved in somatic
FT                                Merkel cell carcinoma; may be associated
FT                                with Cowden syndrome; associated with
FT                                increased manganese superoxide dismutase
FT                                expression; associated with increased
FT                                reactive oxygen species; associated with
FT                                a 2.0-fold increase in AKT expression and
FT                                a 1.7-fold increase in MAPK expression;
FT                                dbSNP:rs11214077).
FT                                {ECO:0000269|PubMed:12007193,
FT                                ECO:0000269|PubMed:12696072,
FT                                ECO:0000269|PubMed:14500403,
FT                                ECO:0000269|PubMed:18678321}.
FT                                /FTId=VAR_017871.
FT   VARIANT      69     69       E -> K (in MT-C2D; results in impaired
FT                                mitochondrial complex II assembly;
FT                                results in impaired cellular respiration;
FT                                dbSNP:rs202198133).
FT                                {ECO:0000269|PubMed:24367056}.
FT                                /FTId=VAR_074105.
FT   VARIANT      81     81       P -> L (in PGL1 and pheochromocytoma;
FT                                dbSNP:rs80338844).
FT                                {ECO:0000269|PubMed:10657297,
FT                                ECO:0000269|PubMed:11156372,
FT                                ECO:0000269|PubMed:15328326}.
FT                                /FTId=VAR_010038.
FT   VARIANT      92     92       D -> G (in MT-C2D; results in highly
FT                                reduced protein expression; results in
FT                                impaired cellular respiration;
FT                                dbSNP:rs786205436).
FT                                {ECO:0000269|PubMed:26008905}.
FT                                /FTId=VAR_074106.
FT   VARIANT      92     92       D -> Y (in PGL1 and pheochromocytoma;
FT                                dbSNP:rs80338845).
FT                                {ECO:0000269|PubMed:10657297,
FT                                ECO:0000269|PubMed:11391798,
FT                                ECO:0000269|PubMed:12000816,
FT                                ECO:0000269|PubMed:15328326}.
FT                                /FTId=VAR_010039.
FT   VARIANT      93     93       Missing (in PGL1).
FT                                {ECO:0000269|PubMed:11391796}.
FT                                /FTId=VAR_018519.
FT   VARIANT     102    102       H -> L (in PGL1; dbSNP:rs104894302).
FT                                {ECO:0000269|PubMed:10657297}.
FT                                /FTId=VAR_010040.
FT   VARIANT     114    114       Y -> C (in PGL1; dbSNP:rs104894304).
FT                                {ECO:0000269|PubMed:11343322,
FT                                ECO:0000269|PubMed:15328326}.
FT                                /FTId=VAR_017872.
FT   VARIANT     139    139       L -> P (in PGL1; dbSNP:rs80338847).
FT                                {ECO:0000269|PubMed:11391798}.
FT                                /FTId=VAR_017873.
FT   VARIANT     145    145       H -> N (found in an individual with
FT                                features of Cowden syndrome; associated
FT                                with increased manganese superoxide
FT                                dismutase expression; associated with
FT                                normal reactive oxygen species;
FT                                associated with no change in AKT
FT                                expression but a 1.2-fold increase of
FT                                MAPK expression; dbSNP:rs11214077).
FT                                {ECO:0000269|PubMed:18678321}.
FT                                /FTId=VAR_054384.
FT   VARIANT     148    148       G -> V (in PGL1).
FT                                {ECO:0000269|PubMed:15328326}.
FT                                /FTId=VAR_054385.
FT   CONFLICT     74     74       V -> F (in Ref. 8; AAH70307).
FT                                {ECO:0000305}.
SQ   SEQUENCE   159 AA;  17043 MW;  6B1AA94831C8C3B6 CRC64;
     MAVLWRLSAV CGALGGRALL LRTPVVRPAH ISAFLQDRPI PEWCGVQHIH LSPSHHSGSK
     AASLHWTSER VVSVLLLGLL PAAYLNPCSA MDYSLAAALT LHGHWGLGQV VTDYVHGDAL
     QKAAKAGLLA LSALTFAGLC YFNYHDVGIC KAVAMLWKL
//
